Skip to main content
. Author manuscript; available in PMC: 2014 Feb 3.
Published in final edited form as: Endoscopy. 2012 Aug 27;44(9):813–818. doi: 10.1055/s-0032-1309837

Table 1.

Baseline characteristics of participants

A. By body mass index (BMI)
Baseline characteristics BMI < 25kg/m2 (N = 466) BMI 25 – 29 kg/m2 (N = 868) BMI ≥ 30kg/m2 (N = 492) P value
Mean age (SD) 61.1 (10.5) 61.1 (9.5) 60.8 (9.7) 0.81
Randomization assignment
Control 236 (50.6) 434 (50.0) 237 (48.2) 0.72
Intervention 230 (49.4) 434 (50.0) 255 (51.8)
Male 226 (48.5) 623 (71.8) 331 (67.3) <0.001
Female 240(51.5) 245(28.2) 161(32.7)
Race
Whites 424 (91.0) 781 (90.0) 428 (87.0)
Blacks 25 (5.4) 70 (8.1) 55 (11.2) 0.005
Others* 17 (3.7) 17 (2.0) 9 (1.8)
Smoking status
Never 192 (41.2) 322 (37.1) 201 (40.9)
Former 183 (39.3) 447 (51.5) 243 (49.4) <0.001
Current 91 (19.5) 99 (11.4) 48 (9.8)
Positive family history of colorectal cancer 116 (24.9) 251 (28.9) 122 (24.8) 0.15
Uses non-steroidal anti-inflammatory drugs at least once/month 160 (34.3) 268 (30.9) 196 (39.8) 0.004
B. By weight change in 4 years
Baseline characteristics No weight change (N = 727) Lost weight (N = 557) Gained weight (N = 542) P value
Mean age (SD) 61.3 (9.4) 63.6 (9.3) 58.0 (10.1) 0.141
Randomization assignment
Control 366 (40.4) 233 (25.7) 308 (34.0) <0.001
Intervention 361 (39.3) 324 (35.3) 234 (25.5)
Male 454 (38.5) 382 (32.4) 344 (29.2) 0.06
Female 273 (42.3) 175 (27.1) 198 (30.7)
Race
Whites 647 (39.6) 502 (30.7) 484 (29.6)
Blacks 60 (40.0) 45 (30.0) 45 (30.0) 0.862
Others* 20 (46.5) 10 (23.3) 13 (30.2)
Smoking status
Never 299 (41.8) 204 (28.5) 212 (29.7)
Former 331 (37.9) 295 (33.8) 247 (28.3) 0.024
Current 97 (40.8) 58 (24.4) 83 (34.9)
Positive family history of colorectal cancer 194 (39.7) 139 (28.4) 156 (31.9) 0.357
Uses non-steroidal anti-inflammatory drugs at least once/month 237 (38.0) 191 (30.6) 196 (31.4) 0.415
*

Others = Hispanics, Asians, Native Americans